Avanos Medical (NYSE:AVNS) Announces Earnings Results

Posted by Francis Steltz on May 6th, 2025

Avanos Medical (NYSE:AVNS – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.07, Zacks reports. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. During the same period last year, the firm posted $0.22 earnings per share. The business’s quarterly revenue was up .8% on a year-over-year basis. Avanos Medical updated its FY 2025 guidance to 0.750-0.950 EPS.

Avanos Medical Stock Up 6.6 %

NYSE:AVNS traded up $0.80 on Tuesday, hitting $12.99. The stock had a trading volume of 261,471 shares, compared to its average volume of 340,448. The company has a market cap of $597.58 million, a PE ratio of 38.21 and a beta of 1.13. The business’s fifty day moving average is $13.62 and its 200 day moving average is $16.26. Avanos Medical has a 52 week low of $11.84 and a 52 week high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Insider Buying and Selling

In related news, SVP Kerr Holbrook sold 7,000 shares of the business’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.25, for a total transaction of $106,750.00. Following the transaction, the senior vice president now directly owns 82,047 shares in the company, valued at approximately $1,251,216.75. The trade was a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.64% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, March 19th.

Get Our Latest Stock Report on Avanos Medical

Avanos Medical Company Profile

(Get Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.